Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis

Kardiologia Polska

Volumn 69, Issue 10, 2011, Pages 1024-1031

  Kabłak Ziembicka, Anna ^a   Przewłocki, Tadeusz ^a   Stȩpień, Ewa ^a   Pienia̧zek, Piotr ^a   Rzeźnik, Daniel ^a   Śliwiak, Dorota ^a   Komar, Monika ^a   Tracz, Wieslława ^a   Podolec, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis biomarkers; Carotid intima media thickness; Cytokines; hs CRP; NT proBNP; Polyvascular atherosclerosis; Risk of cardiovascular event

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIAL WALL THICKENING; ARTERIOSCLEROSIS; ARTERY INTIMA; ARTERY MEDIA; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; RENAL ARTERY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 80054773615     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. American Heart Association. Heart Disease and Stroke Statistics - 2009 Update. Centers for Disease Control and Prevention (CDC)/NCHS and NHLBI 2005-2006.
2. Statistics data from World Health Organisation (http://www.who.int/en).
3. Jakubov S. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome. Curr Med Ris Opin, 2009; 25: 2631-2641.
4. Lanzer P. Vascular multimorbidity in patients with a documented coronary artery disease. Z Kardiol, 2003; 92: 650-659. (Pubitemid 37046721)
5. Przewlocki T, Kablak-Ziembicka A, Kozanecki A et al. Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease. Kardiol Pol, 2009; 67: 978-984.
6. Kashtalap V. Polyvascular atherosclerosis detection in patients with ST elevation myocardial infarction in prognosing the outcome of endovascular coronary revascularisation. EuroIntervention, 2010; 6 (suppl. H): H54.
7. Steg PG, Bhatt DL, Wilson PW et al.; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA, 2007; 297: 1197-206. (Pubitemid 46465728)
8. Thakore AH, Guo CY, Larson MG et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol, 2007; 99: 1598-1602. (Pubitemid 46773027)
9. Blankenberg S, McQueen MJ, Smieja M; HOPE Study Investigators. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation, 2006; 114: 201-208. (Pubitemid 44297113)
10. Jefferis BJ, Whincup PH, Welsh P et al. Circulating TNF-alpha levels in older men and women do not show independent prospective relations with MI or stroke. Atherosclerosis, 2009; 205: 302-308.
11. Karpinski L, Plaksej R, Kosmala W, Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol, 2008; 66: 1279-1285.
12. Gepner AD, Keevil JG, Wyman RA et al. Use of carotid intima- media thickness and "vascular age" to modify cardiovascular risk prediction. J Am Soc Echocardiogr, 2006; 19: 1170-1174. (Pubitemid 44301803)
13. Lorenz MW, von Kegler S, Steinmetz H et al. Carotid intimamedia thickening indicates a higher vascular risk across a wideage range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke, 2006; 37: 87-92. (Pubitemid 43732053)
14. Kablak-Ziembicka A, Przewlocki T, Tracz W et al. Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis. Atherosclerosis, 2007; 193: 395-400. (Pubitemid 47058103)
15. Kablak-Ziembicka A, Przewlocki T, Pieniazek P et al. The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis. Atherosclerosis, 2010; 209: 125-130.
16. Naghavi M, Falk E, Hecht HS et al. From vulnerable plaque to vulnerable patient. Part III. Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol, 2006; 98 (2A): 2H-15H.
17. Kablak-Ziembicka A, Tracz W. Podstawy ultrasonografii naczyńdogłowowych - normy i standardy badań. In: Podolec P, Tracz W, Hoffman P eds. Echokardiografia praktyczna. Vol. 1. Medycyna Praktyczna, Kraków 2004: 245-264.
18. Ramaswami G, Al-Kutoubi A, Nicolaides AN et al. The role of duplex scanning in the diagnosis of lower limb arterial disease. Ann Vasc Surg, 199; 13: 494-500.
19. Drohomirecka A, Kołtowski Ł, Kwinecki P et al. Risk factors for carotid artery disease in patients scheduled for coronary artery bypass grafting. Kardiol Pol, 2010; 68: 789-794.
20. Cicorella N, Zanolla L, Franceschini L et al. Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease. J Cardiovasc Med, 2009; 10: 906-912.
21. Cobble M, Bale B. Carotid intima-media thickness: knowledge and application to everyday practice. Postgraduate Med, 2010; 122: 10-18.
22. Sosnowski C, Pasierski T, Janeczko-Sosnowska E et al. Uwarunkowania grubości błony wewnȩtrznej i środkowej dużych tȩtnic obwodowych. Folia Cardiol, 2005; 12: 382-393.
23. Saremi A, Anderson RJ, Luo P et al.; for the VADT. Association between IL-6 and the extent of coronary atherosclerosis in the Veterans Affairs Diabetes Trial (VADT). Atherosclerosis, 2009; 203: 610-614.
24. Krȩcki R, Krzemińska-Pakuła M, Drożdż J et al. Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease. Cardiol J, 2010; 17: 599-606.
25. Tuomisto K, Jousilahti P, Sundvall J et al. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost, 2006; 95: 511-518.
26. Shlipak MG, Ix JH, Bibbins-Domingo K et al. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med, 2008; 121: 50-57.
27. Ridker PM. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). Thromb Haemost, 2009; 7: 332-339.
28. Welsh P, Woodward M, Rumley A, Lowe G. Associations of circulating TNF-alpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study. Cytokine, 2009; 47: 143-147.
29. Lorenz MW, Markus HS, Bots ML et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation, 2007; 115: 459-467. (Pubitemid 46184197)